Global Infectious Disease Point Of Care Diagnostics Market Research Report 2026(Status and Outlook)

December 2025 | 181 pages | ID: G32886B02923EN
Bosson Research

Abstracts

Point-of-care diagnosis is a test performed on the site of patient care that provides immediate results.Infectious diseases are caused by various microorganisms, such as viruses, bacteria, fungi and parasites.Instant diagnosis of infectious diseases can improve disease management and detection, reducing the time between disease testing and diagnosis of infection.It also reduces postoperative care time, improves outcomes, improves accuracy of outcomes, and provides a simple way to diagnose infectious diseases, broadly reducing the risk of HIV, tuberculosis, influenza, tropical diseases, and sexually transmitted infections.

The global Infectious Disease Point Of Care Diagnostics market size was estimated at USD 6700.42 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.85% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Infectious Disease Point Of Care Diagnostics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Infectious Disease Point Of Care Diagnostics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Infectious Disease Point Of Care Diagnostics market.

Global Infectious Disease Point Of Care Diagnostics Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company
Abbott
Siemens
GE Healthcare
Accriva
Terumo
BioMerieux
Diasorin
Roche
Danaher Corporation
BD
Bio-Rad Laboratories
Cavidi
Cepheid
Diaxonhit
Eiken Chemical
EMD Millipore
Epitope Diagnostic
Euroimmun
Gold Standard Diagnostics
Hologic
Immunetics
InBios International

Market Segmentation (by Type)

Over-the-counter (OTC) Testing Kits
Prescription-based Testing Kits

Market Segmentation (by Application)

Bacterial Infections
Fungal Infection
Virus Infection
Cardiovascular Infection
Gastrointestinal Infection
Sexually Transmitted Disease (STD) Infection
Central Nervous System Infection
Other

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Infectious Disease Point Of Care Diagnostics Market

Overview of the regional outlook of the Infectious Disease Point Of Care Diagnostics Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Infectious Disease Point Of Care Diagnostics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Infectious Disease Point Of Care Diagnostics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Infectious Disease Point Of Care Diagnostics
1.2 Key Market Segments
  1.2.1 Infectious Disease Point Of Care Diagnostics Segment by Type
  1.2.2 Infectious Disease Point Of Care Diagnostics Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 INFECTIOUS DISEASE POINT OF CARE DIAGNOSTICS MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Infectious Disease Point Of Care Diagnostics Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Infectious Disease Point Of Care Diagnostics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 INFECTIOUS DISEASE POINT OF CARE DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Infectious Disease Point Of Care Diagnostics Product Life Cycle
3.3 Global Infectious Disease Point Of Care Diagnostics Sales by Manufacturers (2020-2025)
3.4 Global Infectious Disease Point Of Care Diagnostics Revenue Market Share by Manufacturers (2020-2025)
3.5 Infectious Disease Point Of Care Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Infectious Disease Point Of Care Diagnostics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Infectious Disease Point Of Care Diagnostics Market Competitive Situation and Trends
  3.8.1 Infectious Disease Point Of Care Diagnostics Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Infectious Disease Point Of Care Diagnostics Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 INFECTIOUS DISEASE POINT OF CARE DIAGNOSTICS INDUSTRY CHAIN ANALYSIS

4.1 Infectious Disease Point Of Care Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF INFECTIOUS DISEASE POINT OF CARE DIAGNOSTICS MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Infectious Disease Point Of Care Diagnostics Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy ? April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Infectious Disease Point Of Care Diagnostics Market
5.7 ESG Ratings of Leading Companies

6 INFECTIOUS DISEASE POINT OF CARE DIAGNOSTICS MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Infectious Disease Point Of Care Diagnostics Sales Market Share by Type (2020-2025)
6.3 Global Infectious Disease Point Of Care Diagnostics Market Size by Type (2020-2025)
6.4 Global Infectious Disease Point Of Care Diagnostics Price by Type (2020-2025)

7 INFECTIOUS DISEASE POINT OF CARE DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Infectious Disease Point Of Care Diagnostics Market Sales by Application (2020-2025)
7.3 Global Infectious Disease Point Of Care Diagnostics Market Size (M USD) by Application (2020-2025)
7.4 Global Infectious Disease Point Of Care Diagnostics Sales Growth Rate by Application (2020-2025)

8 INFECTIOUS DISEASE POINT OF CARE DIAGNOSTICS MARKET SALES BY REGION

8.1 Global Infectious Disease Point Of Care Diagnostics Sales by Region
  8.1.1 Global Infectious Disease Point Of Care Diagnostics Sales by Region
  8.1.2 Global Infectious Disease Point Of Care Diagnostics Sales Market Share by Region
8.2 Global Infectious Disease Point Of Care Diagnostics Market Size by Region
  8.2.1 Global Infectious Disease Point Of Care Diagnostics Market Size by Region
  8.2.2 Global Infectious Disease Point Of Care Diagnostics Market Size by Region
8.3 North America
  8.3.1 North America Infectious Disease Point Of Care Diagnostics Sales by Country
  8.3.2 North America Infectious Disease Point Of Care Diagnostics Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Infectious Disease Point Of Care Diagnostics Sales by Country
  8.4.2 Europe Infectious Disease Point Of Care Diagnostics Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Infectious Disease Point Of Care Diagnostics Sales by Region
  8.5.2 Asia Pacific Infectious Disease Point Of Care Diagnostics Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Infectious Disease Point Of Care Diagnostics Sales by Country
  8.6.2 South America Infectious Disease Point Of Care Diagnostics Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Infectious Disease Point Of Care Diagnostics Sales by Region
  8.7.2 Middle East and Africa Infectious Disease Point Of Care Diagnostics Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 INFECTIOUS DISEASE POINT OF CARE DIAGNOSTICS MARKET PRODUCTION BY REGION

9.1 Global Production of Infectious Disease Point Of Care Diagnostics by Region(2020-2025)
9.2 Global Infectious Disease Point Of Care Diagnostics Revenue Market Share by Region (2020-2025)
9.3 Global Infectious Disease Point Of Care Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Infectious Disease Point Of Care Diagnostics Production
  9.4.1 North America Infectious Disease Point Of Care Diagnostics Production Growth Rate (2020-2025)
  9.4.2 North America Infectious Disease Point Of Care Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Infectious Disease Point Of Care Diagnostics Production
  9.5.1 Europe Infectious Disease Point Of Care Diagnostics Production Growth Rate (2020-2025)
  9.5.2 Europe Infectious Disease Point Of Care Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Infectious Disease Point Of Care Diagnostics Production (2020-2025)
  9.6.1 Japan Infectious Disease Point Of Care Diagnostics Production Growth Rate (2020-2025)
  9.6.2 Japan Infectious Disease Point Of Care Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Infectious Disease Point Of Care Diagnostics Production (2020-2025)
  9.7.1 China Infectious Disease Point Of Care Diagnostics Production Growth Rate (2020-2025)
  9.7.2 China Infectious Disease Point Of Care Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Abbott
  10.1.1 Abbott Basic Information
  10.1.2 Abbott Infectious Disease Point Of Care Diagnostics Product Overview
  10.1.3 Abbott Infectious Disease Point Of Care Diagnostics Product Market Performance
  10.1.4 Abbott Business Overview
  10.1.5 Abbott SWOT Analysis
  10.1.6 Abbott Recent Developments
10.2 Siemens
  10.2.1 Siemens Basic Information
  10.2.2 Siemens Infectious Disease Point Of Care Diagnostics Product Overview
  10.2.3 Siemens Infectious Disease Point Of Care Diagnostics Product Market Performance
  10.2.4 Siemens Business Overview
  10.2.5 Siemens SWOT Analysis
  10.2.6 Siemens Recent Developments
10.3 GE Healthcare
  10.3.1 GE Healthcare Basic Information
  10.3.2 GE Healthcare Infectious Disease Point Of Care Diagnostics Product Overview
  10.3.3 GE Healthcare Infectious Disease Point Of Care Diagnostics Product Market Performance
  10.3.4 GE Healthcare Business Overview
  10.3.5 GE Healthcare SWOT Analysis
  10.3.6 GE Healthcare Recent Developments
10.4 Accriva
  10.4.1 Accriva Basic Information
  10.4.2 Accriva Infectious Disease Point Of Care Diagnostics Product Overview
  10.4.3 Accriva Infectious Disease Point Of Care Diagnostics Product Market Performance
  10.4.4 Accriva Business Overview
  10.4.5 Accriva Recent Developments
10.5 Terumo
  10.5.1 Terumo Basic Information
  10.5.2 Terumo Infectious Disease Point Of Care Diagnostics Product Overview
  10.5.3 Terumo Infectious Disease Point Of Care Diagnostics Product Market Performance
  10.5.4 Terumo Business Overview
  10.5.5 Terumo Recent Developments
10.6 BioMerieux
  10.6.1 BioMerieux Basic Information
  10.6.2 BioMerieux Infectious Disease Point Of Care Diagnostics Product Overview
  10.6.3 BioMerieux Infectious Disease Point Of Care Diagnostics Product Market Performance
  10.6.4 BioMerieux Business Overview
  10.6.5 BioMerieux Recent Developments
10.7 Diasorin
  10.7.1 Diasorin Basic Information
  10.7.2 Diasorin Infectious Disease Point Of Care Diagnostics Product Overview
  10.7.3 Diasorin Infectious Disease Point Of Care Diagnostics Product Market Performance
  10.7.4 Diasorin Business Overview
  10.7.5 Diasorin Recent Developments
10.8 Roche
  10.8.1 Roche Basic Information
  10.8.2 Roche Infectious Disease Point Of Care Diagnostics Product Overview
  10.8.3 Roche Infectious Disease Point Of Care Diagnostics Product Market Performance
  10.8.4 Roche Business Overview
  10.8.5 Roche Recent Developments
10.9 Danaher Corporation
  10.9.1 Danaher Corporation Basic Information
  10.9.2 Danaher Corporation Infectious Disease Point Of Care Diagnostics Product Overview
  10.9.3 Danaher Corporation Infectious Disease Point Of Care Diagnostics Product Market Performance
  10.9.4 Danaher Corporation Business Overview
  10.9.5 Danaher Corporation Recent Developments
10.10 BD
  10.10.1 BD Basic Information
  10.10.2 BD Infectious Disease Point Of Care Diagnostics Product Overview
  10.10.3 BD Infectious Disease Point Of Care Diagnostics Product Market Performance
  10.10.4 BD Business Overview
  10.10.5 BD Recent Developments
10.11 Bio-Rad Laboratories
  10.11.1 Bio-Rad Laboratories Basic Information
  10.11.2 Bio-Rad Laboratories Infectious Disease Point Of Care Diagnostics Product Overview
  10.11.3 Bio-Rad Laboratories Infectious Disease Point Of Care Diagnostics Product Market Performance
  10.11.4 Bio-Rad Laboratories Business Overview
  10.11.5 Bio-Rad Laboratories Recent Developments
10.12 Cavidi
  10.12.1 Cavidi Basic Information
  10.12.2 Cavidi Infectious Disease Point Of Care Diagnostics Product Overview
  10.12.3 Cavidi Infectious Disease Point Of Care Diagnostics Product Market Performance
  10.12.4 Cavidi Business Overview
  10.12.5 Cavidi Recent Developments
10.13 Cepheid
  10.13.1 Cepheid Basic Information
  10.13.2 Cepheid Infectious Disease Point Of Care Diagnostics Product Overview
  10.13.3 Cepheid Infectious Disease Point Of Care Diagnostics Product Market Performance
  10.13.4 Cepheid Business Overview
  10.13.5 Cepheid Recent Developments
10.14 Diaxonhit
  10.14.1 Diaxonhit Basic Information
  10.14.2 Diaxonhit Infectious Disease Point Of Care Diagnostics Product Overview
  10.14.3 Diaxonhit Infectious Disease Point Of Care Diagnostics Product Market Performance
  10.14.4 Diaxonhit Business Overview
  10.14.5 Diaxonhit Recent Developments
10.15 Eiken Chemical
  10.15.1 Eiken Chemical Basic Information
  10.15.2 Eiken Chemical Infectious Disease Point Of Care Diagnostics Product Overview
  10.15.3 Eiken Chemical Infectious Disease Point Of Care Diagnostics Product Market Performance
  10.15.4 Eiken Chemical Business Overview
  10.15.5 Eiken Chemical Recent Developments
10.16 EMD Millipore
  10.16.1 EMD Millipore Basic Information
  10.16.2 EMD Millipore Infectious Disease Point Of Care Diagnostics Product Overview
  10.16.3 EMD Millipore Infectious Disease Point Of Care Diagnostics Product Market Performance
  10.16.4 EMD Millipore Business Overview
  10.16.5 EMD Millipore Recent Developments
10.17 Epitope Diagnostic
  10.17.1 Epitope Diagnostic Basic Information
  10.17.2 Epitope Diagnostic Infectious Disease Point Of Care Diagnostics Product Overview
  10.17.3 Epitope Diagnostic Infectious Disease Point Of Care Diagnostics Product Market Performance
  10.17.4 Epitope Diagnostic Business Overview
  10.17.5 Epitope Diagnostic Recent Developments
10.18 Euroimmun
  10.18.1 Euroimmun Basic Information
  10.18.2 Euroimmun Infectious Disease Point Of Care Diagnostics Product Overview
  10.18.3 Euroimmun Infectious Disease Point Of Care Diagnostics Product Market Performance
  10.18.4 Euroimmun Business Overview
  10.18.5 Euroimmun Recent Developments
10.19 Gold Standard Diagnostics
  10.19.1 Gold Standard Diagnostics Basic Information
  10.19.2 Gold Standard Diagnostics Infectious Disease Point Of Care Diagnostics Product Overview
  10.19.3 Gold Standard Diagnostics Infectious Disease Point Of Care Diagnostics Product Market Performance
  10.19.4 Gold Standard Diagnostics Business Overview
  10.19.5 Gold Standard Diagnostics Recent Developments
10.20 Hologic
  10.20.1 Hologic Basic Information
  10.20.2 Hologic Infectious Disease Point Of Care Diagnostics Product Overview
  10.20.3 Hologic Infectious Disease Point Of Care Diagnostics Product Market Performance
  10.20.4 Hologic Business Overview
  10.20.5 Hologic Recent Developments
10.21 Immunetics
  10.21.1 Immunetics Basic Information
  10.21.2 Immunetics Infectious Disease Point Of Care Diagnostics Product Overview
  10.21.3 Immunetics Infectious Disease Point Of Care Diagnostics Product Market Performance
  10.21.4 Immunetics Business Overview
  10.21.5 Immunetics Recent Developments
10.22 InBios International
  10.22.1 InBios International Basic Information
  10.22.2 InBios International Infectious Disease Point Of Care Diagnostics Product Overview
  10.22.3 InBios International Infectious Disease Point Of Care Diagnostics Product Market Performance
  10.22.4 InBios International Business Overview
  10.22.5 InBios International Recent Developments

11 INFECTIOUS DISEASE POINT OF CARE DIAGNOSTICS MARKET FORECAST BY REGION

11.1 Global Infectious Disease Point Of Care Diagnostics Market Size Forecast
11.2 Global Infectious Disease Point Of Care Diagnostics Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Infectious Disease Point Of Care Diagnostics Market Size Forecast by Country
  11.2.3 Asia Pacific Infectious Disease Point Of Care Diagnostics Market Size Forecast by Region
  11.2.4 South America Infectious Disease Point Of Care Diagnostics Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Infectious Disease Point Of Care Diagnostics by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Infectious Disease Point Of Care Diagnostics Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Infectious Disease Point Of Care Diagnostics by Type (2026-2035)
  12.1.2 Global Infectious Disease Point Of Care Diagnostics Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Infectious Disease Point Of Care Diagnostics by Type (2026-2035)
12.2 Global Infectious Disease Point Of Care Diagnostics Market Forecast by Application (2026-2035)
  12.2.1 Global Infectious Disease Point Of Care Diagnostics Sales (K Units) Forecast by Application
  12.2.2 Global Infectious Disease Point Of Care Diagnostics Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Infectious Disease Point Of Care Diagnostics Market Size by Type (M USD)
Table 4. Global Infectious Disease Point Of Care Diagnostics Market Size by Application
Table 5. Infectious Disease Point Of Care Diagnostics Market Size Comparison by Region (M USD)
Table 6. Global Infectious Disease Point Of Care Diagnostics Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Infectious Disease Point Of Care Diagnostics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Infectious Disease Point Of Care Diagnostics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Infectious Disease Point Of Care Diagnostics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Point Of Care Diagnostics as of 2025)
Table 11. Global Market Infectious Disease Point Of Care Diagnostics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Infectious Disease Point Of Care Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Infectious Disease Point Of Care Diagnostics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Infectious Disease Point Of Care Diagnostics Sales by Type (K Units)
Table 27. Global Infectious Disease Point Of Care Diagnostics Market Size by Type (M USD)
Table 28. Global Infectious Disease Point Of Care Diagnostics Sales (K Units) by Type (2020-2025)
Table 29. Global Infectious Disease Point Of Care Diagnostics Sales Market Share by Type (2020-2025)
Table 30. Global Infectious Disease Point Of Care Diagnostics Market Size (M USD) by Type (2020-2025)
Table 31. Global Infectious Disease Point Of Care Diagnostics Market Share by Type (2020-2025)
Table 32. Global Infectious Disease Point Of Care Diagnostics Price (USD/Unit) by Type (2020-2025)
Table 33. Global Infectious Disease Point Of Care Diagnostics Sales (K Units) by Application
Table 34. Global Infectious Disease Point Of Care Diagnostics Market Size by Application
Table 35. Global Infectious Disease Point Of Care Diagnostics Sales by Application (2020-2025) & (K Units)
Table 36. Global Infectious Disease Point Of Care Diagnostics Sales Market Share by Application (2020-2025)
Table 37. Global Infectious Disease Point Of Care Diagnostics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Infectious Disease Point Of Care Diagnostics Market Share by Application (2020-2025)
Table 39. Global Infectious Disease Point Of Care Diagnostics Sales Growth Rate by Application (2020-2025)
Table 40. Global Infectious Disease Point Of Care Diagnostics Sales by Region (2020-2025) & (K Units)
Table 41. Global Infectious Disease Point Of Care Diagnostics Sales Market Share by Region (2020-2025)
Table 42. Global Infectious Disease Point Of Care Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Infectious Disease Point Of Care Diagnostics Market Size by Region (2020-2025)
Table 44. North America Infectious Disease Point Of Care Diagnostics Sales by Country (2020-2025) & (K Units)
Table 45. North America Infectious Disease Point Of Care Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Infectious Disease Point Of Care Diagnostics Sales by Country (2020-2025) & (K Units)
Table 47. Europe Infectious Disease Point Of Care Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Infectious Disease Point Of Care Diagnostics Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Infectious Disease Point Of Care Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Infectious Disease Point Of Care Diagnostics Sales by Country (2020-2025) & (K Units)
Table 51. South America Infectious Disease Point Of Care Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Infectious Disease Point Of Care Diagnostics Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Infectious Disease Point Of Care Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Infectious Disease Point Of Care Diagnostics Production (K Units) by Region(2020-2025)
Table 55. Global Infectious Disease Point Of Care Diagnostics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Infectious Disease Point Of Care Diagnostics Revenue Market Share by Region (2020-2025)
Table 57. Global Infectious Disease Point Of Care Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Infectious Disease Point Of Care Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Infectious Disease Point Of Care Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Infectious Disease Point Of Care Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Infectious Disease Point Of Care Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Abbott Basic Information
Table 63. Abbott Infectious Disease Point Of Care Diagnostics Product Overview
Table 64. Abbott Infectious Disease Point Of Care Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Abbott Business Overview
Table 66. Abbott SWOT Analysis
Table 67. Abbott Recent Developments
Table 68. Siemens Basic Information
Table 69. Siemens Infectious Disease Point Of Care Diagnostics Product Overview
Table 70. Siemens Infectious Disease Point Of Care Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Siemens Business Overview
Table 72. Siemens SWOT Analysis
Table 73. Siemens Recent Developments
Table 74. GE Healthcare Basic Information
Table 75. GE Healthcare Infectious Disease Point Of Care Diagnostics Product Overview
Table 76. GE Healthcare Infectious Disease Point Of Care Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. GE Healthcare Business Overview
Table 78. GE Healthcare SWOT Analysis
Table 79. GE Healthcare Recent Developments
Table 80. Accriva Basic Information
Table 81. Accriva Infectious Disease Point Of Care Diagnostics Product Overview
Table 82. Accriva Infectious Disease Point Of Care Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Accriva Business Overview
Table 84. Accriva Recent Developments
Table 85. Terumo Basic Information
Table 86. Terumo Infectious Disease Point Of Care Diagnostics Product Overview
Table 87. Terumo Infectious Disease Point Of Care Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Terumo Business Overview
Table 89. Terumo Recent Developments
Table 90. BioMerieux Basic Information
Table 91. BioMerieux Infectious Disease Point Of Care Diagnostics Product Overview
Table 92. BioMerieux Infectious Disease Point Of Care Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. BioMerieux Business Overview
Table 94. BioMerieux Recent Developments
Table 95. Diasorin Basic Information
Table 96. Diasorin Infectious Disease Point Of Care Diagnostics Product Overview
Table 97. Diasorin Infectious Disease Point Of Care Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Diasorin Business Overview
Table 99. Diasorin Recent Developments
Table 100. Roche Basic Information
Table 101. Roche Infectious Disease Point Of Care Diagnostics Product Overview
Table 102. Roche Infectious Disease Point Of Care Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Roche Business Overview
Table 104. Roche Recent Developments
Table 105. Danaher Corporation Basic Information
Table 106. Danaher Corporation Infectious Disease Point Of Care Diagnostics Product Overview
Table 107. Danaher Corporation Infectious Disease Point Of Care Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Danaher Corporation Business Overview
Table 109. Danaher Corporation Recent Developments
Table 110. BD Basic Information
Table 111. BD Infectious Disease Point Of Care Diagnostics Product Overview
Table 112. BD Infectious Disease Point Of Care Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. BD Business Overview
Table 114. BD Recent Developments
Table 115. Bio-Rad Laboratories Basic Information
Table 116. Bio-Rad Laboratories Infectious Disease Point Of Care Diagnostics Product Overview
Table 117. Bio-Rad Laboratories Infectious Disease Point Of Care Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Bio-Rad Laboratories Business Overview
Table 119. Bio-Rad Laboratories Recent Developments
Table 120. Cavidi Basic Information
Table 121. Cavidi Infectious Disease Point Of Care Diagnostics Product Overview
Table 122. Cavidi Infectious Disease Point Of Care Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Cavidi Business Overview
Table 124. Cavidi Recent Developments
Table 125. Cepheid Basic Information
Table 126. Cepheid Infectious Disease Point Of Care Diagnostics Product Overview
Table 127. Cepheid Infectious Disease Point Of Care Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Cepheid Business Overview
Table 129. Cepheid Recent Developments
Table 130. Diaxonhit Basic Information
Table 131. Diaxonhit Infectious Disease Point Of Care Diagnostics Product Overview
Table 132. Diaxonhit Infectious Disease Point Of Care Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Diaxonhit Business Overview
Table 134. Diaxonhit Recent Developments
Table 135. Eiken Chemical Basic Information
Table 136. Eiken Chemical Infectious Disease Point Of Care Diagnostics Product Overview
Table 137. Eiken Chemical Infectious Disease Point Of Care Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Eiken Chemical Business Overview
Table 139. Eiken Chemical Recent Developments
Table 140. EMD Millipore Basic Information
Table 141. EMD Millipore Infectious Disease Point Of Care Diagnostics Product Overview
Table 142. EMD Millipore Infectious Disease Point Of Care Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. EMD Millipore Business Overview
Table 144. EMD Millipore Recent Developments
Table 145. Epitope Diagnostic Basic Information
Table 146. Epitope Diagnostic Infectious Disease Point Of Care Diagnostics Product Overview
Table 147. Epitope Diagnostic Infectious Disease Point Of Care Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Epitope Diagnostic Business Overview
Table 149. Epitope Diagnostic Recent Developments
Table 150. Euroimmun Basic Information
Table 151. Euroimmun Infectious Disease Point Of Care Diagnostics Product Overview
Table 152. Euroimmun Infectious Disease Point Of Care Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Euroimmun Business Overview
Table 154. Euroimmun Recent Developments
Table 155. Gold Standard Diagnostics Basic Information
Table 156. Gold Standard Diagnostics Infectious Disease Point Of Care Diagnostics Product Overview
Table 157. Gold Standard Diagnostics Infectious Disease Point Of Care Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Gold Standard Diagnostics Business Overview
Table 159. Gold Standard Diagnostics Recent Developments
Table 160. Hologic Basic Information
Table 161. Hologic Infectious Disease Point Of Care Diagnostics Product Overview
Table 162. Hologic Infectious Disease Point Of Care Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. Hologic Business Overview
Table 164. Hologic Recent Developments
Table 165. Immunetics Basic Information
Table 166. Immunetics Infectious Disease Point Of Care Diagnostics Product Overview
Table 167. Immunetics Infectious Disease Point Of Care Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. Immunetics Business Overview
Table 169. Immunetics Recent Developments
Table 170. InBios International Basic Information
Table 171. InBios International Infectious Disease Point Of Care Diagnostics Product Overview
Table 172. InBios International Infectious Disease Point Of Care Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 173. InBios International Business Overview
Table 174. InBios International Recent Developments
Table 175. Global Infectious Disease Point Of Care Diagnostics Sales Forecast by Region (2026-2035) & (K Units)
Table 176. Global Infectious Disease Point Of Care Diagnostics Market Size Forecast by Region (2026-2035) & (M USD)
Table 177. North America Infectious Disease Point Of Care Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 178. North America Infectious Disease Point Of Care Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 179. Europe Infectious Disease Point Of Care Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 180. Europe Infectious Disease Point Of Care Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 181. Asia Pacific Infectious Disease Point Of Care Diagnostics Sales Forecast by Region (2026-2035) & (K Units)
Table 182. Asia Pacific Infectious Disease Point Of Care Diagnostics Market Size Forecast by Region (2026-2035) & (M USD)
Table 183. South America Infectious Disease Point Of Care Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 184. South America Infectious Disease Point Of Care Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 185. Middle East and Africa Infectious Disease Point Of Care Diagnostics Sales Forecast by Country (2026-2035) & (Units)
Table 186. Middle East and Africa Infectious Disease Point Of Care Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 187. Global Infectious Disease Point Of Care Diagnostics Sales Forecast by Type (2026-2035) & (K Units)
Table 188. Global Infectious Disease Point Of Care Diagnostics Market Size Forecast by Type (2026-2035) & (M USD)
Table 189. Global Infectious Disease Point Of Care Diagnostics Price Forecast by Type (2026-2035) & (USD/Unit)
Table 190. Global Infectious Disease Point Of Care Diagnostics Sales (K Units) Forecast by Application (2026-2035)
Table 191. Global Infectious Disease Point Of Care Diagnostics Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Infectious Disease Point Of Care Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Infectious Disease Point Of Care Diagnostics Market Size (M USD), 2025-2035
Figure 5. Global Infectious Disease Point Of Care Diagnostics Market Size (M USD) (2020-2035)
Figure 6. Global Infectious Disease Point Of Care Diagnostics Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Infectious Disease Point Of Care Diagnostics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Infectious Disease Point Of Care Diagnostics Product Life Cycle
Figure 13. Infectious Disease Point Of Care Diagnostics Sales Share by Manufacturers in 2025
Figure 14. Global Infectious Disease Point Of Care Diagnostics Revenue Share by Manufacturers in 2025
Figure 15. Infectious Disease Point Of Care Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Infectious Disease Point Of Care Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Infectious Disease Point Of Care Diagnostics Revenue in 2025
Figure 18. Industry Chain Map of Infectious Disease Point Of Care Diagnostics
Figure 19. Global Infectious Disease Point Of Care Diagnostics Market PEST Analysis
Figure 20. Global Infectious Disease Point Of Care Diagnostics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Infectious Disease Point Of Care Diagnostics Market Share by Type
Figure 27. Sales Market Share of Infectious Disease Point Of Care Diagnostics by Type (2020-2025)
Figure 28. Sales Market Share of Infectious Disease Point Of Care Diagnostics by Type in 2025
Figure 29. Market Share of Infectious Disease Point Of Care Diagnostics by Type (2020-2025)
Figure 30. Market Share of Infectious Disease Point Of Care Diagnostics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Infectious Disease Point Of Care Diagnostics Market Share by Application
Figure 33. Global Infectious Disease Point Of Care Diagnostics Sales Market Share by Application (2020-2025)
Figure 34. Global Infectious Disease Point Of Care Diagnostics Sales Market Share by Application in 2025
Figure 35. Global Infectious Disease Point Of Care Diagnostics Market Share by Application (2020-2025)
Figure 36. Global Infectious Disease Point Of Care Diagnostics Market Share by Application in 2025
Figure 37. Global Infectious Disease Point Of Care Diagnostics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Infectious Disease Point Of Care Diagnostics Sales Market Share by Region (2020-2025)
Figure 39. Global Infectious Disease Point Of Care Diagnostics Market Size by Region (2020-2025)
Figure 40. North America Infectious Disease Point Of Care Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Infectious Disease Point Of Care Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Infectious Disease Point Of Care Diagnostics Sales Market Share by Country in 2024
Figure 43. North America Infectious Disease Point Of Care Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Infectious Disease Point Of Care Diagnostics Market Size by Country in 2024
Figure 45. U.S. Infectious Disease Point Of Care Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Infectious Disease Point Of Care Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Infectious Disease Point Of Care Diagnostics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Infectious Disease Point Of Care Diagnostics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Infectious Disease Point Of Care Diagnostics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Infectious Disease Point Of Care Diagnostics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Infectious Disease Point Of Care Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Infectious Disease Point Of Care Diagnostics Sales Market Share by Country in 2024
Figure 53. Europe Infectious Disease Point Of Care Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Infectious Disease Point Of Care Diagnostics Market Size by Country in 2024
Figure 55. Germany Infectious Disease Point Of Care Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Infectious Disease Point Of Care Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Infectious Disease Point Of Care Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Infectious Disease Point Of Care Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Infectious Disease Point Of Care Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Infectious Disease Point Of Care Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Infectious Disease Point Of Care Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Infectious Disease Point Of Care Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Infectious Disease Point Of Care Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Infectious Disease Point Of Care Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Infectious Disease Point Of Care Diagnostics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Infectious Disease Point Of Care Diagnostics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Infectious Disease Point Of Care Diagnostics Market Size by Region in 2024
Figure 68. China Infectious Disease Point Of Care Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Infectious Disease Point Of Care Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Infectious Disease Point Of Care Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Infectious Disease Point Of Care Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Infectious Disease Point Of Care Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Infectious Disease Point Of Care Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Infectious Disease Point Of Care Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Infectious Disease Point Of Care Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Infectious Disease Point Of Care Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Infectious Disease Point Of Care Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Infectious Disease Point Of Care Diagnostics Sales and Growth Rate (K Units)
Figure 79. South America Infectious Disease Point Of Care Diagnostics Sales Market Share by Country in 2024
Figure 80. South America Infectious Disease Point Of Care Diagnostics Market Size and Growth Rate (M USD)
Figure 81. South America Infectious Disease Point Of Care Diagnostics Market Size by Country in 2024
Figure 82. Brazil Infectious Disease Point Of Care Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Infectious Disease Point Of Care Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Infectious Disease Point Of Care Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Infectious Disease Point Of Care Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Infectious Disease Point Of Care Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Infectious Disease Point Of Care Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Infectious Disease Point Of Care Diagnostics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Infectious Disease Point Of Care Diagnostics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Infectious Disease Point Of Care Diagnostics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Infectious Disease Point Of Care Diagnostics Market Size by Region in 2024
Figure 92. Saudi Arabia Infectious Disease Point Of Care Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Infectious Disease Point Of Care Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Infectious Disease Point Of Care Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Infectious Disease Point Of Care Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Infectious Disease Point Of Care Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Infectious Disease Point Of Care Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Infectious Disease Point Of Care Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Infectious Disease Point Of Care Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Infectious Disease Point Of Care Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Infectious Disease Point Of Care Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Infectious Disease Point Of Care Diagnostics Production Market Share by Region (2020-2025)
Figure 103. North America Infectious Disease Point Of Care Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Infectious Disease Point Of Care Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Infectious Disease Point Of Care Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Infectious Disease Point Of Care Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Infectious Disease Point Of Care Diagnostics Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Infectious Disease Point Of Care Diagnostics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Infectious Disease Point Of Care Diagnostics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Infectious Disease Point Of Care Diagnostics Market Share Forecast by Type (2026-2035)
Figure 111. Global Infectious Disease Point Of Care Diagnostics Sales Forecast by Application (2026-2035)
Figure 112. Global Infectious Disease Point Of Care Diagnostics Market Share Forecast by Application (2026-2035)